Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-12-10FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for escitalopram oxalate submitted by Macleods Pharmaceuticals Limited. The action updates the appro…
-
FDA approval · 2021-11-24FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for a generic olanzapine and fluoxetine fixed-dose combination product. This approval corre…
-
FDA approval · 2021-11-24FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for the olanzapine and fluoxetine combination product, expanding the regulatory status for …
-
FDA approval · 2021-11-12FDA Approved: DOXEPIN — Supplemental Application (North Star Rx LLC)
The FDA approved a supplemental application for doxepin submitted by North Star Rx LLC. The approval updates the product's labeling.
-
FDA approval · 2021-11-12FDA Approved: QUETIAPINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for a generic quetiapine product (ANDA204203). This marks a supplemental ap…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-11-10FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for Pristiq Extended-Release (desvenlafaxine succinate) from Wyeth Pharmaceuticals (Pfizer).
-
FDA approval · 2021-11-09FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for quetiapine fumarate from Macleods Pharmaceuticals Limited, enabling a generic version of the…
-
FDA approval · 2021-11-02FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for Quetiapine Fumarate from Unichem Pharmaceuticals (USA), Inc. The action approves changes to the …
-
FDA approval · 2021-11-02FDA Approved: PAROXETINE — Original Application (Chartwell RX, LLC.)
FDA approved a generic paroxetine product under an original ANDA submitted by Chartwell RX, LLC.
-
FDA approval · 2021-11-01FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic quetiapine fumarate product from Aurobindo Pharma Limited, enabling its use as a g…
-
FDA approval · 2021-10-04FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Alvogen, Inc.)
FDA approves the sertraline hydrochloride generic under an Original Application filed by Alvogen, Inc. The approval enables marketing of a g…
-
FDA approval · 2021-09-29FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (AiPing Pharmaceutical, Inc.)
FDA approved a supplemental application for Amitriptyline Hydrochloride, a generic product submitted by AiPing Pharmaceutical, Inc., under t…
-
FDA approval · 2021-09-21FDA Approved: CITALOPRAM — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
The FDA approved a supplemental application for Citalopram (generic) from Chartwell Governmental & Specialty RX, LLC.
-
FDA approval · 2021-09-21FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for Fluoxetine Hydrochloride from Lannett Company, Inc., a generic fluoxetine product.
-
FDA approval · 2021-09-21FDA Approved: FLUOXETINE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC)
FDA approved a supplemental application for fluoxetine submitted by Chartwell Governmental & Specialty RX, LLC.
-
FDA approval · 2021-09-21FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Venlafaxine (venlafaxine hydrochloride) from BluePoint Laboratories, confirming the approval of …
-
FDA approval · 2021-09-21FDA Approved: VENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for venlafaxine from Sun Pharmaceutical Industries (ANDA078627).
-
FDA approval · 2021-09-21FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic Venlafaxine manufactured by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceutica…
-
FDA approval · 2021-09-21FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for fluoxetine hydrochloride submitted by PAI Holdings, LLC dba PAI Pharma. The approval updates the…
-
FDA approval · 2021-09-21FDA Approved: ESCITALOPRAM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for escitalopram oxalate (escitalopram) from Sun Pharmaceutical Industries, expanding access to a ge…
-
FDA approval · 2021-09-21FDA Approved: ESCITALOPRAM ORAL SOLUTION — Supplemental Application (Chartwell RX, LLC)
FDA granted a supplemental approval for escitalopram oral solution from Chartwell RX, LLC under ANDA090477, adding an oral solution dosage f…
-
FDA approval · 2021-09-21FDA Approved: ESCITALOPRAM — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for escitalopram by Macleods Pharmaceuticals Limited.
-
FDA approval · 2021-09-21FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc. The approval pertains to changes t…
-
FDA approval · 2021-09-21FDA Approved: CITALOPRAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Citalopram from Hikma Pharmaceuticals USA, updating the generic product's labeling and/or manufa…
-
FDA approval · 2021-09-21FDA Approved: FLUOXETINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for fluoxetine submitted by Torrent Pharmaceuticals Limited.